Cite
Characterization of novel bacteriophage PSKP16 and its therapeutic potential against β-lactamase and biofilm producer strain of K2-Hypervirulent Klebsiella pneumoniae pneumonia infection in mice model.
MLA
Rahimi, Sara, et al. “Characterization of Novel Bacteriophage PSKP16 and Its Therapeutic Potential against β-Lactamase and Biofilm Producer Strain of K2-Hypervirulent Klebsiella Pneumoniae Pneumonia Infection in Mice Model.” BMC Microbiology, vol. 23, no. 1, Aug. 2023, pp. 1–22. EBSCOhost, https://doi.org/10.1186/s12866-023-02979-7.
APA
Rahimi, S., Bakht, M., Javadi, A., Foroughi, F., Marashi, S. M. A., & Nikkhahi, F. (2023). Characterization of novel bacteriophage PSKP16 and its therapeutic potential against β-lactamase and biofilm producer strain of K2-Hypervirulent Klebsiella pneumoniae pneumonia infection in mice model. BMC Microbiology, 23(1), 1–22. https://doi.org/10.1186/s12866-023-02979-7
Chicago
Rahimi, Sara, Mehdi Bakht, Amir Javadi, Farshad Foroughi, Seyed Mahmoud Amin Marashi, and Farhad Nikkhahi. 2023. “Characterization of Novel Bacteriophage PSKP16 and Its Therapeutic Potential against β-Lactamase and Biofilm Producer Strain of K2-Hypervirulent Klebsiella Pneumoniae Pneumonia Infection in Mice Model.” BMC Microbiology 23 (1): 1–22. doi:10.1186/s12866-023-02979-7.